S
Shenzhen Pufei Biotechnology
Innovative biomaterial crafted from fruit waste and algae, offering a sustainable, durable, and biodegradable alternative to leather
About Shenzhen Pufei Biotechnology
PeelSphere operates in the sustainable materials market, focusing on creating innovative biomaterials from fruit waste and algae. The company serves eco-conscious consumers and businesses looking for sustainable alternatives to traditional leather and synthetic materials. PeelSphere's core product is a biodegradable, durable, and versatile material that is designed to reduce carbon footprint and promote circularity. The business model revolves around advanced material engineering to redefine waste and create high-quality, sustainable products. Revenue is generated through the sale of these biomaterials to fashion, interior design, and other industries that prioritize sustainability. PeelSphere's mission is to inspire a sustainable, healthy, and balanced lifestyle through the quality and beauty of its materials.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2022
- Headquarters
- Ningbo, China
- Employees
- 5
- Open positions
- None listed
- Dealroom signal
- 55.2/100
- Industry
- Fashion
- Sector
- Fashion, Biotechnology, Algae, Biomaterials, Organic Waste, Textile Industry, Sustainable Development Goals, Advanced Materials, Climate Tech, Circular Economy
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Shenzhen Pufei Biotechnology.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jun 2026 | $14M | $55M | Shenzhen Capital Group | ↗ |
| SEED✓Equity / VC | Apr 2024 | $2.8M | $11M | China Prosperity Capital · Guangdian Capital · Gopher Ventures | ↗ |
Growth signals
Latest recorded traffic for Shenzhen Pufei Biotechnology is 50 monthly website visits, down 16.7% over the last three months. Shenzhen Pufei Biotechnology's team grew 66.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
China Prosperity Capital
Guangdian Capital- GVGopher Ventures
Series A1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shenzhen Pufei Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shenzhen Pufei Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








